🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether nab-Paclitaxel (Abraxane®...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2015-05-05
Trial ID
NCT02317991
Treatments Being Tested
The purpose of this study is to test how long participants with colorectal ...
Status
Completed
Location
ImClone Investigational Site
Start Date
2009-04
Trial ID
NCT00862784
Treatments Being Tested
The purpose of this study is to assess the effect of concomitant ramuciruma...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2012-10
Trial ID
NCT01634555
Treatments Being Tested
This is a Phase 3 multicenter, randomized study evaluating the safety and e...
Status
Completed
Location
ImClone Investigational Site
Start Date
2010-10
Trial ID
NCT01140347
Treatments Being Tested
This study will test the safety of the combination of ramucirumab and lorla...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Start Date
2023-08-17
Trial ID
NCT06007937
Treatments Being Tested
This is a randomized, open-label, multicenter phase III trial of ramuciruma...
Status
Unknown
Location
Maria Di Bartolomeo
Start Date
2016-12
Trial ID
NCT02934464
Treatments Being Tested
This clinical trial consists of two parts: phase 2 and phase 3. The goal o...
Status
Not Yet Recruiting
Location
Hematology Oncology Associates of the Treasure Coast
Start Date
2026-08-28
Trial ID
NCT07718737
Treatments Being Tested
This phase II trial compares cabozantinib alone and the combination of cabo...
Status
Active Not Recruiting
Location
Veterans Administration Medical Center - Birmingham
Start Date
2020-07-13
Trial ID
NCT04310007
The main purpose of this study is to evaluate the safety of ramucirumab plu...
Status
Completed
Location
UCLA Medical Center
Start Date
2016-02-19
Trial ID
NCT02572687
Treatments Being Tested
This phase II Expanded Lung-MAP treatment trial tests tepotinib with or wit...
Status
Recruiting
Location
Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis
Start Date
2024-08-08
Trial ID
NCT06031688